Smith Ernest S. 4
4 · VACCINEX, INC. · Filed Mar 19, 2019
Insider Transaction Report
Form 4
VACCINEX, INC.VCNX
Smith Ernest S.
SVP, Research & CSO
Transactions
- Award
Stock Option (Right to Buy)
2019-03-15+8,000→ 8,000 totalExercise: $3.90Exp: 2029-03-14→ Common Stock (8,000 underlying)
Holdings
- 5,110
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-23→ Common Stock (5,110 underlying) - 40,729
Stock Option (Right to Buy)
Exercise: $7.10Exp: 2025-12-22→ Common Stock (40,729 underlying) - 16,000
Common Stock
Footnotes (3)
- [F1]Exercisable in full as of the date of this report.
- [F2]This option has vested with respect to 4,088 shares and the remainder vests on December 23, 2019.
- [F3]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date.